TCI Wealth Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Hold
0
1429
2016
Q4
Sell
-1
Closed -$343 1498
2016
Q3
$0 Hold
1
﹤0.01% 1433
2016
Q2
$0 Buy
+1
New +$421 ﹤0.01% 1432
2016
Q1
Sell
-1
Closed 1451
2015
Q4
$0 Hold
1
﹤0.01% 1108
2015
Q3
$1K Hold
1
﹤0.01% 943
2015
Q2
$1K Buy
+1
New +$1.5K ﹤0.01% 933

Other funds holding ONCS

TCI Wealth Advisors's ONCS Position: Q1 2017 in Review

TCI Wealth Advisors held its OncoSec Medical Incorporated (ONCS) position steady in Q1 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

TCI Wealth Advisors first reported a position in ONCS in Q2 2015 and has held it in 5 quarters since. The position peaked at $1K in Q3 2015. 21 funds tracked by Wall St. Rank hold ONCS as of Q1 2017.

  • TCI Wealth Advisors held 0 shares of OncoSec Medical Incorporated worth $0 as of Q1 2017.
  • TCI Wealth Advisors left its OncoSec Medical Incorporated share count unchanged in Q1 2017.
  • OncoSec Medical Incorporated made up ﹤0.01% of TCI Wealth Advisors's portfolio in Q1 2017, its #1429 holding.
  • TCI Wealth Advisors first reported a position in OncoSec Medical Incorporated in Q2 2015 and has held it in 5 quarters since.
  • TCI Wealth Advisors's OncoSec Medical Incorporated position peaked at $1K in Q3 2015.
  • 21 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2017.

Based on TCI Wealth Advisors's 13F filing for Q1 2017, filed 4 May 2017.